Skip to the page

Data / Form D filings / Caldera Therapeutics, Inc.

Caldera Therapeutics, Inc.: Form D filing

Caldera Therapeutics, Inc., a biotechnology company in Cambridge, MA, filed a Form D with the SEC in 2026. The latest, on January 21, 2026, reports $37.5 million sold of a $37.5 million offering to 3 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
300 TECHNOLOGY SQUARE 8TH FLOOR, Cambridge, MA, 02139
Phone
(781) 254-6624
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2025
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2069936

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jan 21, 2026New notice$37,500,000$37,500,0003Jan 8, 2026sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Praveen TipirneniExecutive Officer, Director
Michael GladstoneDirector
Aaron RoystonDirector
Xiaodi SuDirector
Michelle DoigDirector

Other biotechnology companies in Massachusetts that filed recently

Every Form D from the week of Jan 19, 2026 · All recent filings in Massachusetts · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Caldera Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.